UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

James McGough, MD

Print
Email

James McGough, MD

UCLA Physician James McGough, MD specializes in Child & Adolescent Psychiatry.
Specialty
Child & Adolescent Psychiatry
Gender
Male
Language Spoken
English
Hospital Affiliation
Resnick Neuropsychiatric Hospital at UCLA
Ronald Reagan UCLA Medical Center
State License Number
A46192
Contact
(800) 825-9989 Information and referral
Voted Super Doctor
MEDICAL BOARD CERTIFICATION
Addiction Psychiatry, American Board of Psychiatry and Neurology, 1996, 2006
Psychiatry, American Board of Psychiatry and Neurology, 1992
Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology, 1992
EDUCATION
Fellowship
Child Psychiatry, UCLA Neuropsychiatric Hospital, 1989 - 1991
Residency
Psychiatry, Duke University Medical Center Dept. of Psychiatry, 1986 - 1989
Degree
MD, Duke University School of Medicine, 1986
AFFILIATION
MORE INFORMATION
Research Interest
ADHD, Autism Spectrum Disorders, childhood irritability, temper tantrums, severe mood dysregulation
Awards & Recognition
  • 2004 Distinguished Fellow, American Psychiatric Association
  • 2008 Southern California Super Doctors
  • 2009 American Academy of Child and Adolescent Psychiatry Elaine Schlosser Lewis Award for Research on Attention-Deficit Disorder
  • 2009 American Academy of Child and Adolescent Psychiatry Catchers in the Rye Award for Advocacy (AACAP Program Committee)
  • 2010 Southern California Super Doctors
  • 2011 Southern California Super Doctors
  • 2013 Southern California Super Doctors
  • 2013 Distinguished Fellow, American Academy of Child and Adolescent Psychiatry
  • 2013 Master Clinician, American Academy of Child and Adolescent Psychiatry
Publications
  1. McGough JJ and Curry JF. Utility of the SCL-90-R with depressed and conduct disordered adolescents. J Pers Assess. 1992; 59:552-563. PMID 1487808.
  2. Smalley SL, Bailey JN, Palmer CG, Cantwell DP, McGough JJ, Del'Homme M, Asarnow JR, Woodward JA, Ramsey C, Nelson SF. Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry. 1998; 3: 427-430. PMID 9774776.
  3. Palmer CG, Bailey JJ, Ramsey C, Cantwell D, Sinsheimer JS, Del'Homme M, McGough J, Woodward JA, Asarnow R, Asarnow J, Nelson S, Smalley SL. No evidence of linkage or linkage disequilibrium between DAT1 and attention deficit hyperactivity disorder in a large sample. Psychiatr Genet. 1999; 9:157-160. PMID 10551548.
  4. McDougle CJ, Scahill L, McCracken JT, Aman MG, Tierney E, Arnold LE, Freeman BJ, Martin A, McGough JJ, Cronin P, Posey DJ, Riddle MA, Ritz L, Swiezy NB, Vitiello B, Volkmar FR, Votolato NA, Walson P. Research units on pediatric psychopharmacology (RUPP) – autism network: background and rationale for an initial controlled study of risperidone. Child Adolescent Psychiatr Clin North Am. 2000; 9:201-224. PMID 10674197.
  5. Arnold LE, Aman MG, Martin A, Collier-Crespin A, Vitiello B, Tierney E, Asarnow R, Bell-Bradshaw F, Freeman BJ, Gates-Ulanet P, Klin A, McCracken JT, McDougle CJ, McGough JJ, Posey DJ, Scahill L, Swiezy NB, Ritz L, Volkmar F. Assessment in multisite randomized clinical trials (RCTs) of patients with autistic disorder: The autism RUPP network. J Autism Dev Disord. 2000: 30:99-111. PMID 10832774.
  6. Smalley S, McGough J, Del'Homme M, NewDelman J, Gordon E, Kim T, Liu A, McCracken J. Familial clustering of symptoms and disruptive behaviors in multiplex families with attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000: 39:1135-1143.
  7. McCracken JT, Smalley SL, McGough JJ, Crawford L, Del'Homme M, Cantor R, Liu A, Nelson SF. Evidence for linkage of a tandem duplication polymorphism upstream of the dopamine D4 receptor gene (DRD4) with attention deficit hyperactivity disorder (ADHD). Mol Psychiatry. 2000; 5:531-536.
  8. International Molecular Genetic Study of Autism Consortium (IMGSAC). A genomewide scan fro autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am J Hum Genet. 2001;69:570-581.
  9. Scahill L, McCracken J., McDougle CJ, Aman M, Arnold LE, Tierney E, Cronin P, Davies M, Ghuman J, Gonzalez N, Koeini K, Lindsay T, Martin A, McGough J, Posey DJ, Swiezy N, Volkmar F, Ritz L, Vitiello B. Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism. J Child Adolesc Psychopharmacol. 2001: 11:377-388.
  10. Fisher SE, Franks C, McCracken JT, McGough JJ, Marlow AJ, MacPhie IL, Newbury DF, Palmer CGS, Woodward JA, Del'Homme M, Cantwell DP, Nelson SF, Monaco AP, Smalley SL. A genome-wide scan for loci involved in attention-deficit/hyperactivity disorder (ADHD). Am J Hum Genet. 2002; 70:1183-1196.
  11. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Sweizy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez NM, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon D. Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002; 347:314-321.
  12. Smalley SL, Kustanovich V, Minassian SL, Stone J, Ogdie M, McGough JJ, McCracken JT, MacPhie IL, Franks C, Fisher SE, Cantor RM, Monaco AP, Nelson SF. Genetic linkage of attention-deficit hyperactivity disorder (ADHD) on chromosome 16p13 in a region implicated in autism. Am J Hum Genetics. 2002; 71:959-963.
  13. Kustanovich, V, Merriman B, Smalley SL, McGough J, McCracken J, Nelson SF. Biased transmission of SNAP-25 alleles in attention deficit hyperactivity disorder. Mol Psychiatry. 2003; 8:309-315.
  14. McGough JJ, Biederman J, Greenhill LL, McCracken JT, Spencer TJ, Posner K, Wigal S, Gornbein J, Tulloch S, Swanson JM: Pharmacokinetics of SLI381 (Adderall XR), and extended-release formulation of Adderall. J Am Acad Child Adolesc Psychiatry. 2003; 42:684-691.
  15. McCracken JT, Biederman J, Greenhill L, Swanson JM, McGough JJ, Spencer T, Posner K, Wigal S, Tulloch S. Analog classroom assessment of SLI381 in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2003; 42:673-683.
  16. Kotimaa A, Moilanen I, Taanila A, Ebeling H, Smalley SL, McGough J, Hartikainen AL, Jarvelin MR. Maternal smoking and hyperactivity in 8-year old children. J Am Acad Child Adolesc Psychiatry. 2003; 42:826-833.
  17. Ogdie MN, Macphie IL, Minassian SL, Yang M, Fisher SE, Franks C, Cantor R, McCracken JT, McGough JJ, Nelson SF, Monaco AP, Smalley SL. A genome-wide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am J Hum Genetics. 2003; 72:1268-1279.
  18. Loo SK, Fisher SE, Francks C, Ogdie MN, MacPhie L, Yang M, McCracken JT, McGough JJ, Nelson SF, Monaco AP, Smalley SL. Genome-wide scan of reading ability in affected sibling pairs with attention-deficit/hyperactivity disorder: unique and shared genetic effects. Mol Psychiatry. 2004;9:485-493.
  19. Kustanovich V, Ishii J, Crawford L, Yang M, McGough JJ, McCracken JT, Smalley SL, Nelson SF. Transmission disequilibrium testing of dopamine candidate gene polymorphisms in ADHD. Mol Psychiatry. 2004;9:711-717.
  20. Ogdie MN, Fisher SE, Yang M, Ishii J, Franks C, Cantor RM, McCracken JT, McGough JJ, Smalley SL, Nelson SF. Attention deficit hyperactivity disorder: fine mapping support linkage to 5p13, 6q12, 16p13, and 17p11. Am J Hum Genet. 2004;75:661-668.
  21. Abikoff H, McGough J, Vitiello B, McCracken J, Davies M, Walkup J, Riddle M, Oatis M, Greenhill L, Skrobala A, March J, Gammon P, Robinson J, Lazell R, McMahon D, Ritz L. Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity disorder and anxiety disorders. J Am Acad Child Adolesc Psychiatry. 2005;44:418-427.
  22. Lynn DE, Lubke G, Yang M, McCracken JT, McGough JJ, Smalley SL. Temperament and character profiles and the dopamine d4 receptor gene in ADHD. Am J Psychiatry. 2005;162:906-913.
  23. McGough JJ, Biederman J, Wigal S, Lopez FA, McCracken JT, Zhang Y, Tulloch S. Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2005;44:530-538. PMID 15930063.
  24. McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, Koenig K, McGough JJ, Ritz L, Vitiello B. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry. 2005;162:1142-1148. PMID 15930063.
  25. Aman MG, Arnold LE, Lindsay R, Mash P, Hollway J, McCracken JT, Shah B, McGough J, Cronin P, Lee L, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, Martin A, Koenig K, Volkmar F, Carroll D, Lancor A, Tierney E, Ghuman J, Gonzalez N, Grados M, Vitiello B, Ritz L, Davies M, Robinson J, McMahon. Risperidone treatment of autistic disorder: longer term benefits and blinded discontinuation after six months. Am J Psychiatry. 2005;162:1361-1369.
  26. Wigal SB, McGough JJ, McCracken JT, Biederman J, Spencer TJ, Posner KL, Wigal TL, Kollins S, Clark TM, Mays DA, Zhang Y, Tulloch S. Laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention-deficit/hyperactivity disorder. J Att Disord 2005;9:275-289. PMID 16371674.
  27. McGough JJ, Smalley SL, McCracken JT, Yang M, Del'Homme M, Lynn DE, Loo S. Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. Am J Psychiatry. 2005;162:1621-1627. PMID 16135620.
  28. Findling RL, Biederman J, Wilens TE, Spencer TJ, McGough JJ, Lopez FA, Tulloch SJ. Short- and long-term cardiovascular effects of mixed amphetamine sales extended release (Adderall XR) in children. J Pediatr. 2005;147:348-354. PMID 16182674.
  29. Aman MG, Arnold LE, Ramadon Y, Witwer A, Lindsay R, McDougle CJ, Posey DJ, Swiezy N, Kohn A, McCracken JT, Shah B, Cronin P, McGough J, Lee LS, Scahill L, Martin A, Koenig K, Carroll D. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62:1266-1274.
  30. Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Koenig K, McGough J, Gonzalez NM, Swiezy NB, Ritz L, Ghuman J, Lindsay RL. Acute and long-term tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol 2005;15:869-884. PMID 16379507.
  31. Hale TS, McCracken JT, McGough JJ, Smalley SL, Phillips JM, Zaidel E. Impaired linguistic processing and atypical brain laterality in adults with ADHD. Clin Neuroscience Res. 2005;5:255-263.
  32. Hale TS, Zaidel E, McGough JJ, Phillips JM, McCracken JT. Atypical brain laterality in adults with ADHD during dichotic listening for emotional intonation and words. Neuropsychologia. 2006;44:896-904. PMID 16216289.
  33. Wilens TE, McBurnett K, Bukstein O, McGough J, Greenhill, L, Lerner M, Stein MA, Conners CK, Duby J, Newcorn J, Bailey CE, Kratochvil CJ, Coury D, Holland D, Casat C, Denisco MJ, Halstead P, Lynch J, Zimmerman BA, Gu J, Cooper KM, Bowen DL. Multi-site, controlled trial of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med. 2006;160:82-90. PMID 16389216.
  34. McGough JJ, Wigal SB, Abikoff H, Turnbow JM, Posner K, Moon E. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD. J Att Disord. 2006;9:476-485. PMID 16481664.
  35. Pressman L, Loo SK, Carpenter E, Asarnow J, Lynn D, McCracken J, McGough J, Lubke G, Yang MH, Smalley SL. Relationship of family environment and parental psychiatric diagnosis to impairment in ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45:346-354. PMID 16540820.
  36. Biederman J, Wigal S, Spencer T, McGough J, Mays DA. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder. Clin Ther. 2006;28:280-293. PMID 16678649.
  37. McGough JJ, McBurnett K, Buckstein O, Wilens T, Greenhill L, Lerner M, Stein MA, Adolescent Study Group. OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2006;16:351-356. PMID 16768642.
  38. Scahill L, McDougle CJ, Williams SK, Dimitropoulous AM, Aman MG, McCracken J, Tierney E, Arnold E, Cronin P, Grado M, Ghuman J, Koenig K, Langworthy-Lam K, McGough J, Posey DJ, Ritz L, Swiezy NB, Vitiello B. The Children's Yale-Brown Obsessive Compulsive Scale modified for Pervasive Developmental Disorders. J Am Acad Child Adolesc Psychiatry. 2006;45:1114-1123. PMID 16926619.
  39. Kollins SH, Greenhill LL, Swanson J, Wigal S, Abikoff H, McCracken JT, Riddle M, McGough JJ, Vitiello B, Wigal T, Skrobala AM, Posner K, Ghuman JK, Davies M, Cunningham C, Bauzo A. Rationale, design and methods of the preschool ADHD treatment study (PATS). J Am Acad Child Adolesc Psychiatry. 2006;45:1275-1283. PMID 17023870.
  40. Greenhill LL, Kollins S, Abikoff H, McCracken J, Riddle M, Swanson J, McGough J, Wigal S, Wigal T, Vitiello B, Skrobala A, Posner K, Ghuman J, Cunningham C, Davies M, Chuang S, Cooper T. Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45:1284-1293. PMID 17023867.
  41. Swanson J, Greenhill L, Wigal T, Kollins S, Stehli-Nguyen A, Davies M, Chuang S, Vitiello B, Skrobala A, Posner K, Abikoff H, Oatis M, McCracken J, McGough J, Riddle M, Ghuman J, Cunningham C, Wigal S. Stimulant-related growth suppression in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45:1304-1313. PMID 17023868.
  42. Wigal T, Greenhill LL, Chuang S, McGough J, Vitiello B, Skrobala AM. Swanson J, Wigal S, Abikoff H, Kollins SH, McCracken JT, Riddle M, Posner K, Kuar Ghuman J, Davies M, Thorp B, Stehli A. Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45:1294-1303. PMID 17028508.
  43. McGough JJ, McCracken JT, Swanson J, Riddle M, Kollins SH, Greenhill LL, Abikoff H, Davies M, Chuang S, Wigal T, Wigal S, Posner K, Skrobala A, Ghuman J, Cunningham C, Moysiz RK, Vitiello B. Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry. 2006;45:1314-1322. PMID 17023870.
  44. Spencer T, Adler L, McGough J, Muniz R, Kim S, Jiang H, Pestreich L, Agoropoulou C, Etropolski M. Efficacy and safety of dexmethylphenidate extended-release capsules in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;61:1380-1387. PMID 17137560.
  45. Biederman J, Krishnan S, Zhang Y, McGough JJ, Findling RL.: Efficacy and tolerability of lisdexamfetamine dimesylate (LDX; NRP 104) in children with attention-deficit/hyperactivity disorder; a phase III, randomized, multicenter, double-blind, parallel-group study. Clin Ther. 2007;29:430-463. PMID 17577466.
  46. Hurtig T, Ebeling H, Taanila A, Miettunen J, Smalley S, McGough J, Loo S, Jarvelin MR, Moilanen I. ADHD and comorbid disorders in relation to family environment and symptom severity. Eur J Child Adolesc Psychiatry. 2007;16:362-369. PMID 17401612.
  47. Hale TS, Bookheimer S, McGough JJ, Phillips JM, McCracken JT. Atypical brain activation during simple and complex levels of processing in adult ADHD: an fMRI study. J Att Disord. 2007;11:125-139. PMID 17494829.
  48. Posner K, Melvin GA, Murray DW, Gugga SS, Fisher P, Skrobala AM, Cunningham C, Vitiello B, Abikoff HB, Ghuman JK, Kollins SH, Wigal SB, Wigal T, McCracken JT, McGough JJ, Kastelic E, Boorady R, Davies M, Chuang SZ, Swanson JM, Riddle MA, Greenhill LL. Clinical presentation of ADHD in preschool children: the preschool ADHD treatment study (PATS). J Child Adolesc Psychopharmacol. 2007;17:547-562. PMID 17979577.
  49. Ghuman JK, Riddle MA, Vitiello B, Greenhill LL, Chuang SZ, Wigal SB, Kollins SH, Abikoff HB, McCracken JT, Kastelic E, Sharko AM, McGough JJ, Murray D, Evans L, Swanson JM, Wigal T, Posner K, Cunningham C, Davies M, Skrobala AM. Comorbidity moderates response to methylphenidate in the preschoolers with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmaco.l 2007;17:563-580. PMID 17979578.
  50. Abikoff HB, Vitiello B, Riddle MA, Cunningham C, Greenhell LL, Swanson JM, Chuang SZ, Davies M, Kastelic E, Wigal SB, Evans L, Ghuman JK, Kolins SH, McCracken JT, McGough JJ, Murray D, Posner K, Skrobala AM, Wigal T. Methylphenidate effects on functional outcome in the Preschoolers with ADHD Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007;17:581-592. PMID 17979579.
  51. Vitiello B, Abikoff HB, Chuang SZ, Kollins SH, McCracken JT, Riddle MA, Swanson JM, Wigal T, McGough JJ, Ghuman J, Wigal S, Skrobala AM, Davies M, Posner K, Cunningham C, Greenhill LL. Effectiveness of methylphenidate in the 10-month continuation phase of the preschoolers with ADHD treatment study (PATS). J Child Adolesc Psychopharmacol. 2007;17:593-604. PMID 17979580.
  52. Murray DW, Kollins SH, Hardy KK, Abikoff H, Swanson J, Cunningham C, Vitiello B, Riddle M, Davies M, Greenhill L, McCracken J, McGough J, Posner K, Skrobabla A, Wigal T, Wigal S, Ghuman J, Chuang S. Parent vs. teacher ratings of ADHD symptoms in preschoolers. J Child Adolesc Psychopharmacol. 2007;17:605-620. PMID 17979581.
  53. Hardy KK, Kollins SH, Murray DW, Riddle MA, Greenhill LL, Cunningham C, Abikoff HB, McCracken JT, Vitiello B, Davies M, McGough JJ, Posner K, Skrobala AM, Swanson JM, Wigal T, Wigal SB, Ghuman JK, Chuang SZ. Factor structure of parent- and teacher-rated ADHD symptoms in preschoolers. J Child Adolesc Psychopharmacol. 2007;17:621-634. PMID 17979582.
  54. Swanson JM, Moyzis RK, McGough JJ, McCracken JT, Riddle MA, Kollins SH, Greenhill LL, Abikoff HB, Wigal T, Wigal SB, Posner K, Skrobala AM, Ghuman JK, Cunningham C, Vitiello B, Stehli A, Smalley SL. Effects of source of DNA on genotyping success rates and allele percentages in the Preschoolers with ADHD Treatment Study (PATS). J Child Adolesc Psychopharmacol. 2007;17:635-646. PMID 17979583.
  55. Smalley SL, McGough JJ, Moilanen IK, Loo SK, Taanila A, Ebeling H, Hurtig T, Humphrey LA, McCracken JT, Varilo T, Yang MH, Nelson SF, Peltonen L, Jarvelin MR. Prevalence and psychiatric comorbidity of attention deficit hyperactivity disorder in an adolescent Finnish population. J Am Acad Child Adolesc Psychiatry. 2007;46:1575-1583. PMID 18030079.
  56. Lubke GH, Muthen B, Moilanen IK, McGough JJ, Loo SK, Swanson JM, Yang MH, Taanila A, Hurtig T, Jarvelin MR, Smalley SL. Subtypes vs. severity differences in attention deficit hyperactivity disorder in the northern Finnish birth cohort. J Am Acad Child Adolesc Psychiatry. 2007;46:1584-1593. PMID 18030080.
  57. Loo SK, Humphrey LA, Tapio T, Moilanen IK, McGough JJ, McCracken JT, Yang MH, Taanila A, Ebeling H, Jarvelin MR, Smalley S. Executive functioning among Finnish adolescents with attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2007;46:1594-1604. PMID 18030081.
  58. Hurtig T, Ebeling H, Taanila A, Miettunen J, Smalley SL, McGough JJ, Loo SK, Jarvelin MR, Moilanen IK. ADHD symptoms and subtypes: relations between childhood and adolescent symptoms. J Am Acad Child Adolesc Psychiatry. 2007;46:1605-1613. PMID 18030082.
  59. Nyman ES, Ogdie MN, Loukola A, Varilo T, Taanila A, Hurtig T, Moilanen IK, Loo SK, McGough JJ, Jarvelin MR, Smalley SL, Nelson SF, Peltonen L. ADHD candidate gene study in a population-based cohort: association with DBH and DRD2. J Am Acad Child Adolesc Psychiatry. 2007;46:1614-1621. PMID 18030083.
  60. Lu AT, Ogdie MN, Jarvelin M, Moilanen IK, Loo SK, McCracken JT, McGough JJ, Yang MH, Peltonen L, Nelson SF, Cantor RM, Smalley S. Association of the cannabinoid receptor gene (CNR1) with ADHD and comorbid psychiatric disorders. Am J Med Genet B Neuropsychiatric Genet. 2008;147B:1488-1494. PMID 18213623.
  61. Findling RL, Childress AC, Krishnan S, McGough JJ. Long-term effectiveness and safety of lisdexamfetamine dimesylate in school-aged children with attention-deficit/hyperactivity disorder. CNS Spectr. 2008;13:614-620. PMID 18622366.
  62. Loo SK, Rich EC, Ishill J, McGough JJ, McCracken J, Nelson S, Smalley SL. Cognitive functioning in affected sibling pairs with ADHD: familial clustering and dopamine genes. J Child Psychol Psychiatry. 2008;49:950-957. PMID 18665883.
  63. Pierce D, Dixon CM, Wigal SB, McGough JJ. Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study. J Child Adolesc Psychopharmacol. 2008;18:355-364. PMID 18759645.
  64. McGough JJ, Loo SK, McCracken JT, Dang J, Clark S, Nelson SF, Smalley SL. CBCL pediatric bipolar disorder and ADHD: comorbidity and quantitative trait loci analysis. J Am Acad Child Adolesc Psychiatry. 2008;47:1151-1157. PMID 18724256.
  65. Mick E, Neale B, Middleton F, McGough JJ, Faraone SV. Genome-wide association study of response to methylphenidate in 185 children with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatric Genetics. 2008;147B:1412-1418. PMID 18821564.
  66. Zhou K, Dempfle A, Arcos-Burgos M, Bakker SC, Banaschewski T, Biederman J, Buitelaar J, Castellanos FX, Doyle A, Ebstein RP, Ekholm J, Forabosco P, Franke B, Freitag C, Friedel S, Gill M, Hebebrand J, Hinney A, Jacob C, Lesch KP, Loo SK, Lopera F, McCracken JT, McGough JJ, Meyer J, Mick E, Miranda A, Muenke M, Mulas F, Nelson SF, Nguyen TT, Oades RD, Ogdie MN, Palacio JD, Pineda D, Reif A, Renner TJ, Roeyers H, Romanos M, Rothenberger A, Schäfer, Sergeant J, Sinke RJ, Smalley SL, Sonuga-Barke E, Steinhausen HC, van der Meulen E, Walitza S, Warnke A, Lewis CM, Faraone SV, Asherson P. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am J Med Genet B Neuropsychiatric Genetics. 2008;147B:1392-1398. PMID 18821564.
  67. Sallee F, McGough J, Wigal T, Donahue J, Lyne A, Biederman J. Guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder: a placebo controlled trial. J Am Acad Child Adolesc Psychiatry. 2009;4:146-154. PMID 19106767.
  68. Adler LA, Spencer T, McGough JJ, Jiang H, Muniz R. Long-term effectiveness and safety of dexmethylphenidate extended-release capsules in adult ADHD. J Att Dis. 2009;12:449-459. PMID 19218542.
  69. Loo SK, Hale TS, Macion J, Hanada G, McGough JJ, McCracken JT, Smalley SL. Cortical activity pattern in ADHD during arousal, activation and sustained attention. Neuropsychologia. 2009;47:2114-2119. PMID: 19393254.
  70. Hale TS, Smalley SL, Hanada G, Macion J, McCracken JT, McGough JJ, Loo SK. Atypical alpha asymmetry in adults with ADHD. Neuropsychologia. 2009;47:2082-2088. PMID: 19393254.
  71. Sallee FR, Lyne A, Wigal T, McGough JJ. Long-term safety and efficacy of guanfacine extended release in children and adolescent with attention-deficit/hyperactivity disorder. J Child Adoles Psychpharmacol. 2009;19:215-226. PMID: 19519256.
  72. Smalley SL, Loo SK, Hale TS, Shrestha A, McGough J, Flook L, Reise S. Mindfulness and attention deficit hyperactivity disorder. J Clin Psychol. 2009;65:1087-1098. PMID: 19681107.
  73. McGough JJ, McCracken JT, Loo SK, Manganiello M, Leung MC, Tietjens JR, Trinh T, Baweja S, Suddath R, Smalley SL, Helleman G, Sugar C. A candidate gene analysis of methylphenidate response in attention deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2009;12:1155-1164. PMID 19858760.
  74. Hale ST, Smalley SL, Dang J, Hanada G, Macion J, McCracken JT, McGough JJ, Loo SK. ADHD familial loading and abnormal EEG alpha asymmetry in children with ADHD. J Psychiatr Res. 2009;44:605-615. PMID: 200006344.
  75. Findling RL, Adeyi B,Chen G, Dirks B, Babcock T, Scheckner B, Lasser R, Pucci ML, Abdulah HI, McGough JJ. Clinical response and symptomatic remission in children treated with lisdexamfetamine dimesylate for attention-deficit/hyperactivity disorder. CNS Spectr. 2010;15:559-
  76. Rodriguez A, Kaakinen M, Moilanen I, Taanila A, McGough J, Loo S, Jarvelin MR. Mixed handedness is linked to mental health problems in children and adolescents. Pediatrics. 2010;125:e340-348. PMID: 20100759.
  77. Loo SK, Hale TS, Hanada G, Macion J, Shrestha A, McGough JJ, McCracken JT, Nelson S, Smalley SL. Familial clustering and DRD4 effects on electroencephalogram measures in multiplex families with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010:49:368-377. PMID: 20410729.
  78. Hale TS, Smalley SL, Walshaw PD, Hanada G, Macion J, McCracken JT, McGough JJ, Loo SK. Atypical EEG beta asymmetry in adults with ADHD. Neuropyschologia. 2010;48:3532-3529. PMID: 20705076.
  79. Neale BM, Medland SE, Ripke S, Asherson P, Franke B, Lesch KP, Faraone SV, Mguyen TT, Schafer H, Holmans P, Daly M, Steinhausen HC, Fretag C, Reif A, Renner TJ, Nomanos M, romanos J,Walitza S, Warnke A, Meyer J, Palmason H, Buitelaar J, Vasquez AA, Lambregts-Rommelse N, Gill M, anney RJ, Langely K, O'Donovan M, Williams N, Owen M, thapar A, Kent L, Sergeant J, Roeyers H, Mick E, Biederman J, Doyle A, Smalley S, Loo S, Hakonarson H, elia J, Todorov A, Miranda A, Mulas F, Ebstein RP, Rothenberger A, Banaschewski T, Oades RD, Sonuga-Barke E, McGough J, Nisenbaum L, Middleton F, Hu X, Nelson S; Psychiatric GWAS Consortium: ADHD Subgroup. Meta-analysis of genome-wide association studies of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49:884-897. PMID: 20732625.
  80. Mick E, Todorov A, Smalley S, Hu X, Loo S, Todd RD, Biederman J, Byrne D, Dechairo B, Guiney A, McCracken J, McGough J, Nelson SF, Reierson AM, Wilens TE, Wozniak J, Neale BM, Faraone SV, Family-based genome-wide association scan of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2010;49:898-905.
  81. Mick E, McGough JJ, Middleton FA, Neale B, Faraone SV. Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35:466-472. PMID: 21130132.
  82. Schuler J, Weiss NT, Chavira DA, McGough JJ, Berrocal M, Sheppard B, Vaglio E, Fournier E, Herrera LD, Mathews CA. Characteristics and comorbidity of ADHD sib pairs in the Central Valley of Costa Rica. Comp Psychiatry. 2011. epub. PMID: 21696714.
  83. Mick E, McGough J, Loo S, Doyle AE, Wozniak J, Wilens, TE, Smalley S, McCracken J, Biederman J, Faraone SV. Genome-wide association study of the child behavior checklist dysregulation profile. J Am Acad Child Adolesc Psychiatry. 2011;50:807-817. PMID: 21784300.
  84. Berrocal M, Peskin V, Weiss N, Schuler J, Monge S, McGough JJ, Chavira D, Bagnarello M, Herrera LD, Mathews CA. Prevalencia y tamizaje del trastrorno por deficit de atencion con hiperactividad en Costa Rica. Rev Arg de Psiquiat. 2011;22:337-342. PMID 22432094.
  85. McGough JJ, Greenbaum M, Adeyi B, Babcock T, Schenker B, Dirks B, Findling R. Sex subgroup analysis of treatment response to lisdexamfetamine dimesylate in children aged 6 to 12 years with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 2012;32:138-140. PMID: 2217951.
  86. Hinney A, Scherag A, Jarick I, Albayrak Ö, Putter C, Pechlivanis S, Dauverman MR, Beck S, Weber H, Scherag S, Nguyen TT, Volkmar AL, Knoll N, Faraone SV, Neale BM, Franke B, Cichon S, Hoffman P, Nöthen MM, Schreiber S, Jöckel KH, Wichmann HE, Freitag C, Lempp T, Meyer J, Gilsbach S, Herpertz-Dahlmann B, Sinzig J, Lehmkuhl G, Renner TJ, Warnke A, Romanos M, Lesch KP, Reif A, Schimmelmann BG, Hebebrand J, Psychiatric GWAS consortium ADHD subgroup. Genome-wide association study in German patients with attention deficit/hyperactivity disorder. Am J Genet B Neuropsychiatric Genet. 2011;156B:888-897. PMID 22012869.
  87. Stergiakouli E, Hamshere M, Holmans P, Langley K, Zaharieva I, decode Genetics; Psychiatric GWAS Consortium, Hawi A, Kent L, Gill M, Willimas N, Owen MJ, O'Donovan M, Thapar A. Investigating the contribution of common genetic variants to the risk and pathogenesis of ADHD. Am J Psychiatry. 2012;169:186-194. PMID 22420046.
  88. Loo SK, Shtir C, Doyle AE, Mick E, McGough JJ, McCracken J, Biederman J, Smalley SL, Cantor RM, Faraone SV, Nelson SF. Genome-wide association study of intelligence: additive effects of novel brain expressed genes. J Am Acad Child Adolesc Psychiatry. 2012;51:432-440. PMID 22449649.
  89. Nyman ES, Loukola A, Varilo T, Taanila A, Hurtig T, Moilanen I, Loo S, McGough JJ, Järvelin MR, Smalley SL, Nelson SF, Peltonen L. Sex-specific influences of DRD2 on ADHD-type temperament in a large population-based birth cohort. Psychiatric Genet. 2012;22:197-201. PMID 22531292.1.
  90. Bain EE, Robieson W, Pritchett Y, Garimella T, Abi-Saab W, Apostol G, McGough JJ, Saltarelli MD. A randomized, double-blind, placebo-controlled phase 2 study of ?4?2 agonist ABT-894 in adults with ADHD. Neuropsychopharmacology. 2012;epub. PMID: 23032073.
  91. Townsend JD, Sugar CA, Walshaw PD, Vasquez RE, Foland-Ross LC, Moody TD, Bookheimer SY, McGough JJ, Altshuler LL. Frontostriatal neuroimaging findings differ in patients with bipolar disorder who have or do not have ADHD comorbidity. J Affect Disord. 2013;147:389-396. PMID: 23057969.
  92. Hegarty CE, Foland-Ross LC, Narr KL, Sugar CA, McGough JJ, Thompson PM, Altshuler LL. ADHD comorbidity can matter when assessing cortical thickness abnormalities in patients with bipolar disorder. Bipolar Disord. 2012;14:843-855. PMID 23167934.
  93. Loo SK, Cho A, Hale S, McGough JJ, McCracken JT, Smalley SL. Characterization of theta to beta ratio in ADHD: identifying potential sources of heterogeneity. J Atten Disord. 2013;17:384-392. PMID 23264365
  94. Durell TM, Adler LA, Williams DW, Deldar A, McGough JJ, Glaser PE, Rubin RL, Pigott TA, Sarkis EH, Boardman, BK. Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial. J Clin Psychopharmacol. 2013;33:45-54. PMID: 23277268.
  95. Riddle MA, Yershova K, Lazzaretto D, Paykina N, Yenokyan G, Greenhill L, Abikoff H, Vitiello B, Wigal T, McCracken JT, Kollins SH, Murray DW, Wigal S, Kastelic E, McGough JJ, Dosreis S, Bauzo-rosario, Stehli A, Posner K. The preschool attention-deficit/hyperactivity disorder treatment study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry. 2013;52:264-278. PMID 23452683.
  96. Cross-Disorder Group of the Psychiatric Genomics Consortium, Smoller JW, Craddock N, Kendler K, Lee PH, Neale BM, Nurnberger JL, Ripke S, Santangelo S, Sullivan PR. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381:1371-1379. PMID 23453885.
  97. Hamshere ML, Langley K, Martin J, Agha SS, Stergiakouli E, Anney RJ, Buitelaar J, Faraone SV, Lesch KP, Neale MB, Franke B, Sonuga-Barke E, Asherson P, Merwood A, Kuntsi J, Medland SE, Ripke S, Steinhausen HC, Freitag C, Refi A, Renner TJ, Romanos M, Romanos J, Wanke A, Meyer J, Palmason H, Vasquez AA, Lambregts-Rommeise N, Roeyers H, Biederman J, Doyle AE, Hakonsarson H, Rothenberger A, Banaschewski T, Oades RD, McGough JJ, Kent L, Williams N, Owens MJ, Holmans P, O'Donovan MC, Thapar A. High loading of polygenic risk for ADHD in children with comorbid aggression. Am J Psychiatry. 2013;170:909-916. PMID 23599091.
  98. Yang L, Neale BM, Liu L, Lee SH, Wray NR, Ji N, Li H, qian Q, Wang D, Li J, Faraone SV, Wang Y, Psychiatric GWAS Consortium: ADHD Subgroup. Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet. 2013;162B:419-430. PMID 23728934.
  99. Cross-Disorder Group of the Psychiatric Genetics Consortium. Genetic relationships between five psychiatric disorders estimated from genome-wide SNPs. Nat Genet. 2013;45:984-994.. PMID 23933821.
  100. McGough JJ, McCracken JT, Cho AL, Castelo E, Sturm A, Cowen J, Piacentini J, Loo SK. A potential electroencephalography and cognitive biosignature for the child behavior checklist dysregulation profile. J Am Acad Child Adolesc Psychiatry. 2013;52:1173-1182. PMID 24157391.
  101. Lenartowicz A, Delorme A, Walshaw PD, Cho AL, Bilder RM, McGough JJ, McCracken JT, Makeig S, Loo s. Electroencephalography correlates of spatial working memory deficits in attention-deficit/hyperactivity disorder. J Neurosci. 2014;34:1171-1182. PMID 24453310.
  102. Mick E, McGough J, Deutsch CK, Frazier JA, Kennedy D, Goldberg RJ. Genome-wide association study of proneness to anger. PLoS One. 2014;9:e87257. PMID 24489884.
  103. Congdon E, Altshuler LL, Mumford JA, Karisgodt KH, Sabb FW, Ventura J, McGough JJ, London ED, Cannon TD, Bilder RM, Poldrack RA. Neural activation during response inhibition in adult attention-deficit/hyperactivity disorder. Psychiatry Res. 2014;222:17-28. PMID 24581734.
  104. Hart AB, Gamazon ER, Engelhardt BE, Sklar P, Kahler AK, Hultman CM, Sullivan PF, Neale BM, Faraone SV; Psychiatric Genomics Consortium: ADHD Subgroup, de Wit H, Cox NH, Palmer AA. Genetic variation associated with euphorigenic effects of d-amphetamine is associated with diminished risk for schizophrenia and attention deficit hyperactivity disorder. Proc Natl Acad Sci USA. 2014;111:5968-5973. PMID 24711425.
  105. Leuchter AF, McGough JJ, Cook IA, Korb AS, Hunter AM, Glaser PE, Deldar A, Durell TM. Neurophysiologic predictors of response to atomoxetine in attention deficit/hyperactivity disorder: a pilot project. J Psychiatr Res. 2014;15:11-18. PMID 24726639.
  106. Hale TS, Kane AM, Kaminsky O, Tung KL, Wiley JF, McGough JJ, Loo SK, Kaplan JT. Visual network asymmetry and default mode network function in ADHD: an fMRI study. Front Psychiatry. 2014;5:81. PMID 25076915
  107. Hale TS, Kane AM, Tung KL, Kaminsky O, McGough JJ, Hanada G, Loo SK. Abnormal parietal brain function in ADHD: replication and extension of previous EEG beta asymmetry findings. Front Psychiatry. 2014;5:87. PMID 25104941.
Back to top
Referring a Patient to UCLA
Our staff will assist you in selecting the appropriate UCLA clinical department for your patient.

Find out how to refer a patient
James McGough, click here to update your profile.